JPH119196A - Prevention of loss in livestock with chitosan - Google Patents
Prevention of loss in livestock with chitosanInfo
- Publication number
- JPH119196A JPH119196A JP9167597A JP16759797A JPH119196A JP H119196 A JPH119196 A JP H119196A JP 9167597 A JP9167597 A JP 9167597A JP 16759797 A JP16759797 A JP 16759797A JP H119196 A JPH119196 A JP H119196A
- Authority
- JP
- Japan
- Prior art keywords
- livestock
- chitosan
- infectious diseases
- preventing
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、家畜の損耗防止の
方法に関し、キトサンを家畜に経口投与して感染症予防
することによる、家畜の損耗防止の方法に関する。TECHNICAL FIELD The present invention relates to a method for preventing livestock abrasion, and more particularly to a method for preventing livestock abrasion by orally administering chitosan to livestock to prevent infectious diseases.
【0002】[0002]
【従来の技術】キトサンは天然多糖類で、通常カニ、エ
ビなどの甲殻等から得られるキチンをアルカリ処理、酵
素処理等により脱アセチル化することで得られる。さら
に詳細には、カニ、エビを原料として、蛋白、カルシウ
ムを除いたキチンをさらに脱アセチル化し、脱アセチル
化度(糖鎖中のグルコサミン残基割合)が50%以上で、
希酸可溶になったものをいう。2. Description of the Related Art Chitosan is a natural polysaccharide and is obtained by deacetylation of chitin, which is usually obtained from crustacean and shrimp shells, by alkali treatment, enzyme treatment, or the like. More specifically, using crab and shrimp as raw materials, chitin excluding protein and calcium is further deacetylated, and the degree of deacetylation (the ratio of glucosamine residues in the sugar chain) is 50% or more.
It is one that has become soluble in dilute acid.
【0003】家畜の感染症予防のため、家畜の飼料に添
加剤を加える方法が従来から行われており、添加剤とし
て抗生物質(特開昭46-4380,特公昭51-21997,特開昭52-
130925,特開昭54-52731,特開昭54-70289,特開昭55-1607
67)、乳酸菌(特開平07-126178)、酵母菌(特開平08-
283175)、初乳の発酵乳(特開昭55-19002)が知られて
いる。これらの方法は、コストが高くコスト対効果の面
で必ずしも満足が得られないとか、コストは安いが十分
に効果が認められないなど問題がある。[0003] In order to prevent infectious diseases in livestock, a method of adding an additive to livestock feed has conventionally been used. 52-
130925, JP-A-54-52731, JP-A-54-70289, JP-A-55-1607
67), lactic acid bacteria (JP-A-07-126178), yeasts (JP-A-08-126178)
283175), and fermented milk of colostrum (JP-A-55-19002) are known. These methods have problems such as high cost and not always satisfactory in terms of cost effectiveness, or low cost but insufficient effect.
【0004】[0004]
【発明が解決しようとする課題】家畜の肺炎や細菌性下
痢等の罹患による成長の停止・遅延、死亡などは酪農家
にとって大きな問題である。特に分娩後・離乳後の幼畜
では肺炎や細菌性下痢症が多発し死の転帰をとる例が多
い。また本症への罹患により発育遅延に陥る例も多いこ
とから、その経済的損失は大きい。肺炎や細菌性下痢症
を発症した家畜に対しては、抗生物質等の治療がなされ
るが、生産コストの上昇につながる。また、本症の予防
のために抗生物質等の飼料への添加が行われるが、作業
性、コスト、休薬期間などの面で問題がある。そのた
め、感染症を予防できる、効果・作業性・コスト・休薬
期間等で問題のない、家畜の損耗防止の方策が切望され
ている。Problems to be solved by the present invention Stopping and delaying growth and death of livestock due to pneumonia and bacterial diarrhea are major problems for dairy farmers. In particular, infants after childbirth and after weaning often have pneumonia and bacterial diarrhea, which often results in death. In addition, there are many cases in which growth is delayed due to the onset of this disease, and the economic loss is large. Livestock that have developed pneumonia or bacterial diarrhea are treated with antibiotics and the like, but this leads to an increase in production costs. In addition, antibiotics and the like are added to feed to prevent this disease, but there are problems in terms of workability, cost, and drug holiday. Therefore, there is an urgent need for a measure for preventing livestock abrasion, which can prevent infectious diseases, has no problems in efficacy, workability, cost, and drug holiday.
【0005】[0005]
【課題を解決するための手段】本発明者らは上記課題を
解決するべく鋭意研究を重ねた結果、驚くべきことにキ
トサンを家畜に経口投与することにより、感染症予防で
きることを見いだし、本発明を完成させた。Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventors surprisingly found that oral administration of chitosan to livestock can prevent infectious diseases. Was completed.
【0006】[0006]
【発明の実施の形態】以下に本発明を詳細に説明する.
本発明はキトサンを家畜に経口的に投与し、感染症予防
することにより家畜の損耗防止する方法である。損耗と
は発育の停止・遅延及び死亡をいう。また、本発明でい
う感染症の種類としては家畜により様々であるあるが、
微生物が生体宿主に侵入し定着、増殖する病気の全てを
いう。感染症の中でも特に呼吸器及び消化器の感染症予
防に効果が認められる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail.
The present invention is a method for preventing the consumption of livestock by administering orally chitosan to livestock and preventing infectious diseases. Attrition refers to cessation / delay of growth and death. The type of infectious disease referred to in the present invention varies depending on the livestock,
It refers to all diseases in which microorganisms invade living colonies and colonize and proliferate. Particularly effective in preventing respiratory and digestive tract infections among infectious diseases.
【0007】本発明でいう家畜としては牛、馬、豚及び
鶏などが挙げられるが特に限定するものではない。キト
サンによる感染症予防効果は、成熟家畜の中で免疫力が
低下している家畜、及び免疫力が弱い幼畜においてより
強く認められる。さらに、子牛において感染症予防効果
が顕著である。[0007] Livestock as referred to in the present invention include cattle, horses, pigs and chickens, but are not particularly limited. The effect of preventing infectious diseases by chitosan is more strongly observed in livestock with reduced immunity among mature livestock and in young animals with weak immunity. Furthermore, the infectious disease prevention effect is remarkable in calves.
【0008】本発明のキトサン経口剤の形態・形状とし
ては錠剤、丸剤、顆粒、細粒、粉末、半固形剤、液剤、
カプセルなどがあるが、特に液剤が取扱安く、飼料に添
加の際に均一に混合しやすいなどの面で優れている。[0008] The form and shape of the oral chitosan preparation of the present invention include tablets, pills, granules, fine granules, powder, semi-solid preparation, liquid preparation,
There are capsules and the like, but they are particularly excellent in that liquids are easy to handle and easy to mix evenly when added to feed.
【0009】キトサンの経口投与方法としては、キトサ
ン経口剤を家畜へ直接経口投与する方法及びキトサン経
口剤を飼料や飲水に混合してから投与する方法がある
が、何れでもよい。キトサンの投与量としては200〜100
0mg/頭/日である。投与期間としては特に限定しない
が、効果を期待するには、キトサン経口剤又はキトサン
含有飼料を一定の期間継続して与えることが必要であ
る。例えば子牛の下痢症または肺炎の予防には、以下の
実施例に示す如く、10〜14日間経口投与することによ
り、その効果を発揮し得る。[0009] As an oral administration method of chitosan, there is a method of directly administering an oral preparation of chitosan to livestock and a method of mixing the oral preparation of chitosan into feed or drinking water and then administering it. 200 to 100 doses of chitosan
0 mg / head / day. The administration period is not particularly limited, but in order to expect the effect, it is necessary to continuously give an oral chitosan or a chitosan-containing feed for a certain period. For example, for the prevention of calf diarrhea or pneumonia, the effect can be exerted by oral administration for 10 to 14 days as shown in the following examples.
【0010】[0010]
【実施例】以下に実施例をあげて本発明をさらに詳細に
説明し、本発明の効果を明らかにするが、これらは単な
る例示であって、これらにより本発明の範囲が限定され
るものではない。EXAMPLES The present invention will be described in more detail with reference to the following examples to clarify the effects of the present invention. However, these are merely examples, and the scope of the present invention is not limited by these examples. Absent.
【0011】実施例1(液体経口剤の調製) キトサン原末4gを水600〜700mlに膨潤させ、酢酸2ml
を加え、撹拌して溶解した後、水で全量1Lとし、キト
サン液体経口剤を得た。以下の実施例に供した。Example 1 (Preparation of liquid oral preparation) Chitosan bulk powder (4 g) was swollen in water (600-700 ml), and acetic acid (2 ml)
Was added to the mixture, and the mixture was dissolved by stirring. The total amount was adjusted to 1 L with water to obtain a chitosan liquid oral preparation. The following examples were used.
【0012】実施例2 T農場において生後7〜10日目の子牛3頭に対し、キト
サン経口剤50mL(キトサン200mg含有)を1日2回ミルク
に混合し、1週間投与した(キトサン投与群)。対照とし
てキトサンを投与していない子牛(対照群)3頭を用い、
全6頭にSalmonella dublin 109個静脈注射により人工
感染させ、その後の各個体の症状を観察した。キトサン
投与群はその後2週間キトサン経口剤投与を継続した。
対照群は肺炎の症状を示し、抗生物質での治療を行なっ
た。キトサン投与群では糞便中から排菌は続くものの、
臨床症状はほとんどなく順調に成育した。Example 2 Three calves aged 7 to 10 days old at T Farm were mixed with 50 mL of an oral chitosan (containing 200 mg of chitosan) twice a day in milk and administered for 1 week (chitosan administration group). As controls, three calves to which chitosan was not administered (control group) were used.
Were artificially infected with Salmonella dublin 10 9 pieces injected intravenously all six horses were observed symptoms of each subsequent individual. The chitosan administration group continued oral administration of chitosan for 2 weeks thereafter.
The control group showed symptoms of pneumonia and was treated with antibiotics. In the chitosan administration group, evacuation continues from feces,
She grew well with little clinical symptoms.
【0013】実施例3 K牧場において導入子牛50頭のうち26頭をキトサン投与
群、24頭を対照群として試験を実施した。キトサン経口
剤は50mL(キトサン200mg含有)を1日2回ミルクに混合
し、導入当日から10〜14日間投与した。下痢、肺炎等の
抗生物質等による治療は従来通りに行うこととし、治療
回数の比較を実施した。対照群では治療に及んだ例が見
られたのに対し、投与群では治療した例は見られなかっ
た。Example 3 A test was carried out on a K pasture with 26 out of 50 calves introduced as a chitosan-administered group and 24 as a control group. For oral chitosan, 50 mL (containing 200 mg of chitosan) was mixed with milk twice a day and administered for 10 to 14 days from the day of introduction. Treatment with antibiotics for diarrhea, pneumonia and the like was performed as usual, and the number of treatments was compared. In the control group, there were cases in which treatment was observed, whereas in the administration group, no cases were treated.
【0014】実施例4 T農場において導入した臨床的に健康な子牛(ホルスタ
イン種雄)10頭に、1頭当たりキトサン経口剤50mL(キト
サン200mg含有)を代用乳2Lに混合し、1日2回、16日
間投与し、キトサン無投与群10頭を対照として投与効果
を比較した。対照群10頭中1例に下痢便の排泄が確認さ
れたが、投与群では呼吸器及び消化器の症状を示したも
のはいなかった。投与期間中の増体重は投与区で1頭当
たり平均12.1kg、対照区で7.1kgであり、1日当たり増
体重はそれぞれ426g、259gであった。Example 4 To 10 clinically healthy calves (Holstein male) introduced at T farm, 50 mL of chitosan oral preparation (containing 200 mg of chitosan) was mixed with 2 L of milk replacer per cow twice a day. , For 16 days, and the administration effect was compared using 10 mice as a control without chitosan administration. Excretion of diarrheal stool was confirmed in 1 out of 10 animals in the control group, but none of the administration groups showed respiratory and digestive symptoms. The body weight gain during the administration period was 12.1 kg per animal on average in the administration group, and 7.1 kg in the control group, and the body weight gain per day was 426 g and 259 g, respectively.
【0015】[0015]
【発明の効果】本発明に従えば、キトサンを有効成分と
する経口剤又はキトサン含有の飼料、飲水などを家畜に
投与することにより、家畜の呼吸器及び消化器系の感染
症を予防することができる。そのため、家畜の損耗を防
止することができる。According to the present invention, an oral preparation containing chitosan as an active ingredient or a feed or drinking water containing chitosan is administered to livestock to prevent infectious diseases of the respiratory and digestive systems of the livestock. Can be. Therefore, it is possible to prevent livestock from being worn.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 木村 文男 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 (72)発明者 坂井 政世 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 (72)発明者 伊藤 寿一 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 (72)発明者 坂下 満明 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 (72)発明者 村岡 高志 香川県観音寺市三本松町4−2−35 株式 会社加ト吉バイオ内 (72)発明者 次田 隆志 香川県観音寺市三本松町4−2−35 株式 会社加ト吉バイオ内 (72)発明者 矢田谷 健 栃木県塩谷郡氏家町氏家3469−65 Jap an Calf Clinic内 (72)発明者 秋山 和夫 北海道足寄郡陸別町旭町 十勝農業共済組 合内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Fumio Kimura Inventor, Pharmaceutical Research Laboratories, Meiji Seika Co., Ltd., 760 Morioka-cho, Kohoku-ku, Yokohama, Kanagawa Prefecture Address Meiji Seika Co., Ltd., Pharmaceutical Research Laboratory (72) Inventor Juichi Ito 760 Morioka-cho, Kohoku-ku, Yokohama-shi, Kanagawa Prefecture Meiji Seika Co., Ltd. 760 Okamachi Meiji Seika Co., Ltd., Pharmaceutical Research Institute (72) Inventor Takashi Muraoka 4-2-35 Sanbonmatsucho, Kanonji-shi, Kagawa Pref. -2-35 Katoyoshi Bio Co., Ltd. (72) Inventor Takeshi Kenya 3469-65 Ja, Ujiiecho, Shioya-gun, Tochigi Prefecture In an Calf Clinic (72) inventor Kazuo Akiyama Hokkaido Ashoro-gun Rikubetsu MachiAsahi-cho, Tokachi agricultural mutual aid union within the
Claims (7)
防することを特徴とする家畜の損耗防止の方法。1. A method for preventing livestock wear, which comprises administering chitosan orally to livestock to prevent infectious diseases.
項1記載の家畜の損耗防止の方法。2. The method according to claim 1, wherein the animal is prevented from being worn by preventing respiratory and digestive organ infections.
及び2記載の家畜の損耗防止の方法。3. Livestock with reduced and weak immunity.
And 2. The method for preventing livestock abrasion described in 2.
の方法。4. The method according to claim 3, which is a young animal.
の方法。5. The method according to claim 4, wherein the method is a calf.
に用いるキトサン経口剤。6. An oral chitosan preparation for use in the method for preventing livestock wear according to claim 1.
剤。7. The oral chitosan preparation according to claim 6, which is a liquid preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9167597A JPH119196A (en) | 1997-06-24 | 1997-06-24 | Prevention of loss in livestock with chitosan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9167597A JPH119196A (en) | 1997-06-24 | 1997-06-24 | Prevention of loss in livestock with chitosan |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH119196A true JPH119196A (en) | 1999-01-19 |
Family
ID=15852727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9167597A Pending JPH119196A (en) | 1997-06-24 | 1997-06-24 | Prevention of loss in livestock with chitosan |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH119196A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002238466A (en) * | 2001-01-31 | 2002-08-27 | Iji Biosystem:Kk | Feed additive |
JP2005289839A (en) * | 2004-03-31 | 2005-10-20 | Natl Inst Of Radiological Sciences | Life prolonging agent and use thereof |
JP2007520202A (en) * | 2003-06-20 | 2007-07-26 | ニュートリニア・リミテッド | Method for protecting biologically active compounds and compositions containing same |
JPWO2005087241A1 (en) * | 2004-03-16 | 2008-01-24 | コンビ株式会社 | Infection control agent for livestock, poultry or seafood |
CN103705533A (en) * | 2012-09-29 | 2014-04-09 | 洛阳惠中兽药有限公司 | Pharmaceutical composition for preventing poultry infectious diseases, preparation method thereof, and applications thereof |
JP2017079673A (en) * | 2015-10-30 | 2017-05-18 | 森永乳業株式会社 | Elephant artificial milk |
US10046032B2 (en) | 2016-03-24 | 2018-08-14 | Nutrinia, Ltd. | Use of insulin for promoting gastric emptying |
-
1997
- 1997-06-24 JP JP9167597A patent/JPH119196A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002238466A (en) * | 2001-01-31 | 2002-08-27 | Iji Biosystem:Kk | Feed additive |
JP2007520202A (en) * | 2003-06-20 | 2007-07-26 | ニュートリニア・リミテッド | Method for protecting biologically active compounds and compositions containing same |
US8877232B2 (en) | 2003-06-20 | 2014-11-04 | Nutrinia Ltd. | Bioactive compounds protection method and compositions containing the same |
US9750699B2 (en) | 2003-06-20 | 2017-09-05 | Nutrinia Ltd. | Bioactive compounds protection method and compositions containing the same |
US9943485B2 (en) | 2003-06-20 | 2018-04-17 | Nutrinia Ltd. | Bioactive compounds protection method and compositions containing the same |
JPWO2005087241A1 (en) * | 2004-03-16 | 2008-01-24 | コンビ株式会社 | Infection control agent for livestock, poultry or seafood |
JP2005289839A (en) * | 2004-03-31 | 2005-10-20 | Natl Inst Of Radiological Sciences | Life prolonging agent and use thereof |
CN103705533A (en) * | 2012-09-29 | 2014-04-09 | 洛阳惠中兽药有限公司 | Pharmaceutical composition for preventing poultry infectious diseases, preparation method thereof, and applications thereof |
CN103705533B (en) * | 2012-09-29 | 2016-12-21 | 洛阳惠中兽药有限公司 | Pharmaceutical composition of preventing and treating poultry infectious disease and its preparation method and application |
JP2017079673A (en) * | 2015-10-30 | 2017-05-18 | 森永乳業株式会社 | Elephant artificial milk |
US10046032B2 (en) | 2016-03-24 | 2018-08-14 | Nutrinia, Ltd. | Use of insulin for promoting gastric emptying |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101406166B (en) | Segregated early weaning method of piglet | |
EP0800394A1 (en) | Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals | |
JPH0655107B2 (en) | Anti-pseudorabies and anti-pathogenic feed and feed additives for livestock, poultry and seafood | |
CN105941870A (en) | Nanometer montmorillonite feed additive compound for detoxifying and diarrhea prevention of livestock and poultry | |
JPH119196A (en) | Prevention of loss in livestock with chitosan | |
CN107712353A (en) | A kind of feed addictive for preventing diarrhea of pigs and preparation method and application | |
WO2013000093A1 (en) | Location-specific bacterial management | |
WO2011099000A2 (en) | Pharmaceutical composition for treating the gastrointestinal tract | |
JP3224131B2 (en) | Immunostimulatory / infective protective agent containing two or more bacteria, egg white and garlic | |
JPH0984529A (en) | Cattle and poultry feed containing mannan originated from microorganism | |
JP3534792B2 (en) | Disease resistant feed | |
JP3051268B2 (en) | Immunostimulation / infection protective agent | |
CN107960543A (en) | A kind of suckling piglet glycine type additive premix | |
JPS61277630A (en) | Breeding of animal | |
JP5072286B2 (en) | Animal immunomodulator | |
JP2002507123A (en) | Method for improving the effectiveness of probiotics, preparation of nutritional additives and animal feed containing same | |
JP2001008636A (en) | Feed composition for preventing infectious disease | |
US20090092641A1 (en) | Uses of natural immunobiotic extract | |
RU2352344C2 (en) | Method of cows endometritis prevention | |
US3790669A (en) | Synergistic tylosin and furazolidone medication for calf pneumoenteritis complex | |
RU2415684C2 (en) | Pharmaceutical composition for treatment and/or prevention of intestinal disbiosis in process of antibacterial therapy in warm-blooded animals: cattle, pigs, domestic animals, in particular dogs, cats and poultry and method of treatment and/or prevention of intestinal disbiosis in process of antibacterial therapy in warm-blooded animals: cattle, pigs, domestic animals, in particular dogs, cats and poultry | |
CN113244220A (en) | Application of potassium dehydroandrographolide succinate in preparation of veterinary drug for treating cow mastitis and potassium dehydroandrographolide succinate veterinary drug | |
CN112203523A (en) | Probiotic composition for use in feed additives | |
AU698600B2 (en) | Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hindgut associated with acidic conditions in humans and animals | |
CN108888762A (en) | A kind of composition of the metabolite containing probiotics |